CTTHOTCPharmaceutical PreparationsFiscal year ends December 31

CTT PHARMACEUTICAL HOLDINGS, INC.

Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Sep 17, 2026

$0.06−0.00 (-0.17%)

Close on Oct 16, 2026

Market cap: $1.26M
P/E (TTM): –
Dividend yield: –

CTT PHARMACEUTICAL HOLDINGS, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q3 2015 2015-09-30	Q2 2015 2015-06-30	Q1 2015 2015-03-31	Q4 2014 2014-12-31	Q3 2014 2014-09-30	Q2 2014 2014-06-30	Q1 2014 2014-03-31	Q4 2013 2013-12-31	Q3 2013 2013-09-30	Q2 2013 2013-06-30	Q1 2013 2013-03-31	Q4 2012 2012-12-31	Q3 2012 2012-09-30	Q2 2012 2012-06-30	Q1 2012 2012-03-31	Q4 2011 2011-12-31	Q3 2011 2011-09-30	Q2 2011 2011-06-30	Q1 2011 2011-03-31	Q4 2010 2010-12-31	Q3 2010 2010-09-30	Q2 2010 2010-06-30
General & Administrative	0.01	0.00	0.03	0.00	0.01	0.00	0.00	0.00	0.00	0.03	0.04	0.04	0.01	0.05	0.06	0.05	0.04	0.21	0.01	0.01	0.22	0.07
Advertising Expenses	0.00	0.00	0.00	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Expenses	0.34	0.36	0.34	0.63	0.04	0.00	0.00	0.01	0.01	0.06	0.06	0.20	0.12	0.19	0.58	0.19	0.11	0.44	0.03	0.56	0.98	0.39
Operating Income	–	–	-0.34	–	–	-0.02	0.00	0.13	-0.03	-0.06	-0.06	-0.20	-0.12	-0.19	-0.58	-0.19	-0.11	-0.44	-0.03	-0.56	-0.98	-0.39
Income from Equity Investments	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	-0.23	-0.36	-0.68	-0.26	0	0	–
Income Tax Expense	–	–	–	–	–	–	–	–	0	–	–	–	0.00	–	–	–	0	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-0.11	-0.43	–	–	-0.87	0.00
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	–	–	-0.04	-0.42	0.00
Net Income	-0.34	-0.36	-0.34	-0.63	-0.04	0.00	0.00	-0.01	-0.01	-0.06	-0.04	-0.18	-0.11	-0.04	-0.58	-0.43	-0.44	-1.08	5.69	-0.51	-0.44	0.00
EPS (Basic)(per share)	-0.03	0.00	-0.0013	0.00	-0.01	0.00	-0.0006	0.00	-0.01	-0.0006	-0.0006	0.00	-0.0006	0.00	-0.0038	0.00	-0.0031	-0.0075	0.04	0.00	-0.0031	0.00
EPS (Diluted)(per share)	-0.03	0.00	-0.0013	0.00	-0.01	0.00	-0.0006	0.00	0.00	-0.0006	-0.0006	0.00	-0.0006	0.00	-0.0038	0.00	-0.0031	-0.0075	0.04	0.00	-0.0031	0.00
Shares Outstanding (Basic, Weighted)(shares)	21	341	312	197	16	239	239	149	149	151	151	151	149	149	151	144	142	142	142	142	137	133
Shares Outstanding (Diluted, Weighted)(shares)	21	341	312	197	16	239	239	149	149	151	151	151	149	149	152	156	142	142	148	142	137	133
EBITDA	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-0.19	-0.11	–	–	-0.56	-0.96	-0.36

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Sep 30, 2015

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2014: -91.9%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1.70
Dividend yield: –